Showing results (181-190 of 415) with videos related to
Sort By:
Pageof 42
Gastro Hep Advances|June 15, 2026
Evidence Supporting Utility of the Oral Cholate Challenge Test of Liver Function and Physiology to Aid Clinical Management: A Review of Analytical and Clinical Validation StudiesAndrew P Keaveny, Kamran Qureshi, Mitchell Shiffman, et al.Plos One|March 29, 2016
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C CohortGraham R Foster, Carmine Coppola, Moutaz Derbala, et al.Journal of Hepatology|February 21, 2006
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CDaniele Prati, Mitchell L Shiffman, Moisés Diago, et al.World Journal of Gastroenterology|December 7, 2016
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained countryNaomi Khaing Than Hlaing, Debolina Banerjee, Robert Mitrani, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2004
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcomeKirti Shetty, Kate Timmins, Colleen Brensinger, et al.Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.Gastroenterology|December 4, 2004
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levelsStefan Zeuzem, Moisés Diago, Edward Gane, et al.Alimentary Pharmacology & Therapeutics|November 11, 2024
Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V StudyMitchell Shiffman, K Rajender Reddy, Michael D Leise, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2004
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinomaNoriyo Yamashiki, Jeffrey J Gaynor, Tomoaki Kato, et al.Pageof 42